资生堂求解医美赛道

Core Viewpoint - Shiseido has launched its first medical beauty brand, RQPYOLOGY, marking its entry into the medical aesthetics market amid declining performance over recent years. The company aims to leverage the growing market potential, but faces competition from established players like L'Oréal and Estée Lauder [1][3]. Group 1: Brand Launch and Product Information - RQPYOLOGY is positioned as a high-end medical beauty brand that integrates skin care with medical aesthetics, targeting consumers seeking professional beauty results and premium experiences [3]. - The brand has successfully registered two products: RQPYOLOGY Brightening Essence and RQPYOLOGY Sunscreen, and plans to collaborate with medical clinics and hospitals in China for product development [3][4]. Group 2: Market Context and Strategic Moves - Shiseido's management has expressed intentions to enter the medical aesthetics market, supported by investments and collaborations, including partnerships with domestic medical technology firms and research institutions [4]. - The medical aesthetics market is projected to grow significantly, with estimates suggesting an increase from 99.3 billion yuan in 2017 to 638.2 billion yuan by 2030, indicating a high growth rate and potential for high-margin opportunities [7]. Group 3: Financial Performance and Challenges - Shiseido has faced declining sales, with net sales of 990.6 billion yen in 2024, a 1.8% increase, but a core operating profit decrease of 35 billion yen, and a net loss of 108 billion yen [5]. - The company has experienced a downward trend in performance over the past few years, with net sales dropping by 8.8% in 2023 and a significant decline in operating profit and net profit [5]. Group 4: Competitive Landscape - Major beauty brands like L'Oréal and Estée Lauder are also expanding into the medical aesthetics sector, indicating a trend among beauty companies to seek higher value and profit margins in this area [7][8]. - The medical aesthetics market requires a higher level of professionalism and involves medical-grade systems, presenting challenges for beauty companies that primarily operate in brand and channel management [9].